The company has taken a major step forward in regaining US Medicare coverage.
2:22 pm today
Non-executive independent director Anna Stove, chief executive Dr Peter Meintjes, chief financial officer Grant Gibson, director global marketing Mike Hankey.
Cancer diagnostics company Pacific Edge believes a return to profitability is now on the cards after taking a major step forward in regaining US Medicare coverage.
Key numbers for the 12 months ended March compared with a year ago:
Net loss $35.8m vs $29.9m
'Very cheap': Why analysts believe F&P Healthcare is tipped for a rebound
NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth
DC Healthcare Sustains Turnaround Momentum with RM21.36 Million Revenue in Q1 FY2026
Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company
ZTEST Electronics Inc. Announces Fiscal 2026 Q3 Results with 13.9% Year Over Year Revenue Growth
Psyence Group Inc. Announces Results of Annual General and Special Meeting of Shareholders
Five owners in 20 years: I-MED shows how deals have changed
Fisher & Paykel Healthcare profit jumps 24% to $468.5m as hospital demand surges
Cenexi recovery, new product launches and capacity additions power Gland Pharma outlook
Nanalysis Announces First Quarter 2026 Results
Craigs now rates F&P Healthcare 'overweight', calling the stock oversold.
TORONTO, ON / ACCESS Newswire / May 21, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial…
Results exceeded market expectations and included an 18 percent jump in revenue for its hospital business.
KUALA LUMPUR, MY / ACCESS Newswire / May 25, 2026 / DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), a medical…
From turmoil to transformation, Clarity Medical Group CEO Jiang Bo charts a fresh course with governance reform, insurance…
Amplia Therapeutics has launched a pivotal registration-enabling trial of narmafotinib for pancreatic cancer, testing better…
